Healthcare -
Biotechnology - NASDAQ - US
$ 0.5209
-5.54 %
$ 44.9 M
Market Cap
-0.33
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Century Therapeutics, Inc.
| Revenue | 6.59 M |
| Cost Of Revenue | 13.3 M |
| Gross Profit | -6.72 M |
| Operating Expenses | 145 M |
| Operating Income | -138 M |
| Other Expenses | -11.6 M |
| Net Income | -127 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 6.6 | 2.2 | 5.2 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 13.3 | 13.0 | 10.1 | 4.6 | 1.8 | 0.2 |
| Gross Profit | (6.7) | (10.8) | (4.9) | (4.6) | (1.8) | (0.2) |
| OPERATING INCOME | ||||||
| Operating Expenses | 144.7 | 148.8 | 139.0 | 94.9 | 49.2 | 20.0 |
| Selling, General and Administrative Expenses | 33.2 | 34.7 | 31.9 | 19.2 | 9.5 | 5.8 |
| Research and Development Expenses | 107.2 | 92.7 | 107.2 | 75.6 | 39.7 | 14.3 |
| Operating Income | (138.1) | (146.5) | (133.8) | (94.9) | (53.9) | (246.0) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0.5 | 1.1 | 1.3 | 0.4 | 0 |
| Total Other Income | 13.4 | 11.8 | 3.0 | (0.9) | 0.3 | 1.2 |
| Pre-Tax Income | (124.8) | (134.8) | (130.8) | (95.8) | (53.6) | (244.8) |
| NET INCOME | ||||||
| Tax Provision | 1.8 | 1.9 | 91 K | 43 K | 1.1 | 1.2 |
| Net Income | (126.6) | (136.7) | (130.9) | (95.8) | (54.7) | (246.0) |
| EPS | 1.61 | 2.3 | 2.27 | 1.74 | 1 | 4.49 |